Download PDF

Other users also viewed these articles

FEV1Q as a Predictive Metric for Asthma Outcomes Diana Betancor; Jose Maria Olaguibel; Victoria del Pozo; Maria Jose Alvarez Puebla; Ebymar Arismendi; Blanca Barroso; Irina Bobolea; Blanca Cárdaba; José Antonio Cañas; Javier Domínguez-Ortega; María-Jesús Cruz; Elena Curto; Alberto Garcia de la Fuente; Francisco Jose González-Barcala; Juan-Alberto Luna-Porta; Cesar Martínez-Rivera; Joaquim Mullol; Xavier Muñoz; César Picado; Vicente Plaza; Santiago Quirce; Manuel Jorge Rial; Lorena Soto-Retes; Marcela Valverde-Monge; Ignacio Mahíllo-Fernández; Joaquin Sastre;
Arch Bronconeumol. 2025;61:434-7
Comparison of Long-term Response and Remission to Omalizumab and Anti-IL-5/IL-5R Using Different Criteria in a Real-life Cohort of Severe Asthma Patients Marcela Valverde-Monge; Patricia Sánchez-Carrasco; Diana Betancor; Blanca Barroso; José Manuel Rodrigo-Muñoz; Ignacio Mahillo-Fernández; Ebymar Arismendi; Irina Bobolea; Blanca Cárdaba; María Jesús Cruz; Victoria Del Pozo; Javier Domínguez-Ortega; Francisco Javier González-Barcala; José María Olaguibel; Juan Alberto Luna-Porta; Carlos Martínez-Rivera; Joaquim Mullol; Xavier Muñoz; Lorena Peleteiro-Pedraza; Cesar Picado Valles; Vicente Plaza; Santiago Quirce; Manuel Jorge Rial; Lorena Soto-Retes; Antonio Valero; Joaquín Sastre;
Arch Bronconeumol. 2024;60:23-32
Therapeutic Goals and Treatable Traits: Long-Term Trends in a Severe Asthma Population Carlos Almonacid-Sánchez; Borja G. Cosío; Andrea Trisán-Alonso; Francisco Javier Callejas-González; Carolina Cisneros; Eva Martínez-Moragón; Vicente Plaza Moral; Elisabeth Vera; José Gregorio Soto-Campos; Carlos Martínez-Rivera; Bernardino Alcazar-Navarrete; Isabel Urrutia Landa; Juan Luis García-Rivero; Alicia Padilla Galo; Francisco Álvarez-Gutierrez; Jacinto Ramos-González; José Ángel Carretero-Gracia; Inmaculada Lluch; Luis Puente; Rubén Andujar-Espinosa; Luis Pérez-de-Llano;
Arch Bronconeumol. 2023;59:842-5